Literature DB >> 30288856

Identification of incident pancreatic cancer in Ontario administrative health data: A validation study.

Jennifer W Wu1,2, Laurent Azoulay1,2,3, Anjie Huang4, Michael Paterson4,5,6, Fangyun Wu4, Matthew H Secrest2, Kristian B Filion1,2,7.   

Abstract

PURPOSE: To validate three approaches for identifying incident cases of pancreatic cancer in Ontario administrative claims data.
METHODS: We created a cohort using Ontario (Canada) administrative health data from 2002 to 2012 and identified cases of pancreatic cancer with three approaches, using the Ontario Cancer Registry (OCR) as the reference standard. In the any diagnosis approach, cases were defined by primary or secondary diagnostic codes for pancreatic cancer in outpatient or inpatient records. In the any inpatient diagnosis approach, cases were defined using only diagnoses in hospital discharge abstracts. In the algorithm approach, cases were identified by an algorithm that combined the first two approaches. Comparing each approach to the OCR, we calculated the expected value and 95% confidence interval (CI) of the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). We also compared the event dates using each approach with those recorded in the OCR.
RESULTS: Among a total of 12 060 837 patients in Ontario administrative health data sources, 13 999 incident pancreatic cancer cases were identified in the OCR. Sensitivity ranged from 72.5% (algorithm) to 97.5% (any diagnosis), and PPV ranged from 38.4% (any diagnosis) to 78.9% (any inpatient diagnosis). Specificity and NPV were ~100% for all approaches. The median absolute difference in cancer event date ranged 0 to 15 days. The any inpatient diagnosis method had the highest PPV (78.9%; 95% CI: 78.2-79.5%) and moderate sensitivity (86.6%; 95% CI: 86.0-87.2%).
CONCLUSION: Inpatient diagnoses of pancreatic cancer in Ontario administrative heath data are suitable for pancreatic cancer case identification.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  administrative health databases; cancer registry; pancreatic cancer; pharmacoepidemiology; validation

Mesh:

Year:  2018        PMID: 30288856     DOI: 10.1002/pds.4641

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Identification of cancer patients using claims data from health insurance systems: A real-world comparative study.

Authors:  Hongrui Tian; Ruiping Xu; Fenglei Li; Chuanhai Guo; Lixin Zhang; Zhen Liu; Mengfei Liu; Yaqi Pan; Zhonghu He; Yang Ke
Journal:  Chin J Cancer Res       Date:  2019-08       Impact factor: 5.087

2.  Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.

Authors:  Devin Abrahami; Antonios Douros; Hui Yin; Oriana Hy Yu; Jean-Luc Faillie; François Montastruc; Robert W Platt; Nathaniel Bouganim; Laurent Azoulay
Journal:  BMJ       Date:  2018-12-05

3.  Increased Risk of Hospitalization for Pancreatic Cancer in the First 8 Years after a Gestational Diabetes Mellitus regardless of Subsequent Type 2 Diabetes: A Nationwide Population-Based Study.

Authors:  Julien Simon; Karine Goueslard; Patrick Arveux; Sonia Bechraoui-Quantin; Jean-Michel Petit; Catherine Quantin
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

4.  Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study.

Authors:  Enrico Longato; Barbara Di Camillo; Giovanni Sparacino; Lara Tramontan; Angelo Avogaro; Gian Paolo Fadini
Journal:  Cardiovasc Diabetol       Date:  2021-11-13       Impact factor: 9.951

5.  Patient, physician and geographic predictors of cardiac stress testing strategy in Ontario, Canada: a population-based study.

Authors:  Idan Roifman; Lu Han; Jiming Fang; Anna Chu; Peter Austin; Dennis T Ko; Pamela Douglas; Harindra Wijeysundera
Journal:  BMJ Open       Date:  2022-03-10       Impact factor: 2.692

6.  Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea.

Authors:  Min Soo Yang; Minae Park; Joung Hwan Back; Gyeong Hyeon Lee; Ji Hye Shin; Kyuwoong Kim; Hwa Jeong Seo; Young Ae Kim
Journal:  Cancer Res Treat       Date:  2021-08-02       Impact factor: 5.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.